Johnson & Johnson has announced that its Janssen Pharmaceutical Companies has signed two memorandums of understanding (MoUs) with distinguished partners in Saudi Arabia as part of the company’s commitment to advancing global health. The two MoUs cover different scopes of activities and are designed to address current health needs, advance science and research, and bring innovative treatments and solutions to patients. Speaking on the partnerships, Vishnu Kalra, Managing Director for ...